# About MOTS-c peptide Source: An Independent Research Digest

> MOTS-c peptide Source is an independent editorial project publishing plain-English, cited summaries of the MOTS-c research literature. Not a clinic, not a vendor, no medical advice.

An independent editorial read of the mitochondrial-derived-peptide literature.

## What This Site Is

MOTS-c Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on MOTS-c. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The approach is borrowed from thermography — the practice of rendering invisible signals as a readable heat map. Established preclinical findings are logged where they run hot; the honest gaps — no human trials, no validated pharmacokinetics — are logged where they read cold. The aim is a calibrated read of what the studies actually measured, with the regulatory and research-use status read first.

## What the Name Means

The word "Source" in the name is editorial framing. It marks the position this publisher occupies relative to the literature — a place that reads the science back to its sources and logs it straight — not a claim to be a vendor, a supplier, or a place that sells anything. MOTS-c is sold only as a research chemical for laboratory use, and this site sells nothing and recommends no supplier. The distinction is deliberate: the name describes an editorial stance toward the record, not a commercial service.

We take no position on whether anyone should use MOTS-c. We describe what published animal and cell studies have reported, cite each figure, and state the limits of the evidence plainly. Where a fact is uncertain or unestablished, we say so rather than fill the gap.

## How We Handle the Evidence

Every quantitative claim on this site is tied to a numbered citation on the [full reference list](/references), drawn from PubMed-indexed studies and, for regulatory statements, from FDA sources. Animal and cell findings are labeled as such; human associations are kept separate from interventional outcomes. We do not convert rodent doses into human guidance, and we publish no dosing instructions or protocols. When the literature is thin or contested — single-lab findings, ancestry-dependent responses, the m.1382A>C diabetogenic variant — we flag it rather than smooth it over.

---

A thermographic read of the MOTS-c record — each finding logged at the temperature its data actually run and the research-use and FDA standing read before anything else; no clinic behind the instrument and nothing here dispensed or sold.